As of 14 Oct 2026, Kardigan has raised $300M across 1 verified round on record; latest: $300 million Series A, announced 10 Jan 2025.
Kardigan is a heart health company focused on developing treatments and technologies for cardiovascular diseases.
kardigan.bioSouth San Francisco and Princeton, New JerseyBiotechPublic company
1 source
Published by hand (fiercebiotech.com): "Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer the leading cause of death worldwide, the company announced in a Jan. 10 release.": biggest-rounds completeness (K): hand-checked, the cited page states $300 million
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $300M | 2025-01-10 | not stated | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source Published by hand (fiercebiotech.com): "Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer the leading cause of death worldwide, the company announced in a Jan. 10 release.": biggest-rounds completeness (K): hand-checked, the cited page states $300 million | ||||